The barriers are real. The gaps in diagnosis, treatment and support aren't just statistics — they're lived experiences that demand action.
Changing what it means to live with a rare disease isn't something any one of us can do alone. It's something we pioneer together with
We're transforming the future of healthcare by unlocking the power of what science can do.
Community Guidelines: bit.ly/2MgAcio
- 32 young leaders from 24 countries. One shared goal: better health. Meet our 2026 Young Health Programme Impact Fellows and Scholars taking action on health equity, health systems resilience and climate and nature. With @OneYoungWorld and @YouthAssembly. #YoungHealthProgramme
- For #Investors and #Media only. Our H1 2026 results are now available, highlighting strong growth momentum, with Total Revenue up 6% and continued pipeline delivery. Learn more: learn.az/6012BEvvGp #AZN #FinancialResults $AZN
- Named among @TIME World's Most Sustainable Companies for the third consecutive year. Sustainability is embedded in our strategy and how we operate — helping us build a more resilient, efficient business as we deliver life-changing medicines and support a healthier future for
- We focus on advancing research and understanding of generalised myasthenia gravis (MG), guided by those affected and aiming to improve care and outcomes. #MGAwarenessMonth #MyastheniaGravis #RareDiseases

